ArticleActa neuropathologica communications2025

Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomas.

Drew Duckett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.